Brief: Freeline Therapeutics Holdings PLC Announces Updated Development Plan And Timelines For FLT190 For People With Fabry Disease

Freeline Therapeutics Holdings

24/03/2022 11:16

March 24 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE THERAPEUTICS HOLDINGS PLC - ANNOUNCES UPDATED
DEVELOPMENT PLAN AND TIMELINES FOR FLT190 FOR PEOPLE WITH FABRY
DISEASE
    * FREELINE THERAPEUTICS HOLDINGS PLC - COMPANY TO PROGRESS
TO
SECOND DOSE COHORT IN MARVEL-1 STUDY IMMEDIATELY,
    * FREELINE THERAPEUTICS HOLDINGS PLC - FIRST PATIENT DOSING
EXPECTED IN MID-2022
    * FREELINE THERAPEUTICS HOLDINGS PLC - PLANS TO PROVIDE AN
UPDATE
ON ITS FABRY PROGRAM IN SECOND HALF OF 2022

Source text for Eikon:  ID:nGNX3pSx3t 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))